Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB05
- Pharmacological subgroupB05X
- Chemical subgroupB05XA
- Chemical substanceB05XA06Potassium phos incl comb w/0th pot. salts
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 47 registrations
- Potassium Phosphate Monobasic Injection176 MG / ML · Solution · Sandoz Canada Incorporated
- Anticoagulant Solution Citrate Phosphate Dextrose (CPD)3.27 G / L + 25.5 G / L + 26.3 G / L + 2.51 G / L · Solution · Maco Pharma
- Glycerolyte 57 Solution57 G / 100 ML + 30 MG / 100 ML + 1.6 G / 100 ML + 124.2 MG / 100 ML + 51.7 MG / 100 ML · Solution · Fresenius Kabi AG
- Isolyte S PH 7.4 (Multi-Electrolyte Injection)30 MG / 100 ML + 37 MG / 100 ML + 820 MCG / 100 ML + 370 MG / 100 ML + 530 MG / 100 ML + 500 MG / 100 ML + 12 MG / 100 ML · Solution · B. Braun Medical INC
Brazil
Anvisa · 25 registrations
At a glance
- ATC code
- B05XA06
- ATC group
- Blood and blood-forming organs
- Registers
- 5
- Historical lists
- 1
- Registrations
- 112
- With their own page
- 47
- Companies
- 73
All medicines with Monobasic
Human medicines from every register that match Monobasic by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
109 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Monobasic Sodium Phosphate and Dibasic Sodium PhosphateCombination | United States | 0.398GM; 1.102GM | tablet | Marketed | Novel Labs INC |
| Potassium Phosphate Monobasic Injection | Canada | 176 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| Ionosol MB and Dextrose 5% in Plastic ContainerCombination | United States | 5GM/100ML; 30MG/100ML; 141MG/100ML; 15MG/100ML; 260MG/100ML; 25MG/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Isolyte S PH 7.4 in Plastic ContainerCombination | United States | 30MG/100ML; 37MG/100ML; 0.82MG/100ML; 370MG/100ML; 530MG/100ML; 500MG/100ML; 12MG/100ML | injectable | Marketed | B Braun |
| Sodium Phosphates in Plastic ContainerCombination | United States | 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Hospira |
| Dextrose 5% and Electrolyte No. 48 in Plastic ContainerCombination | United States | 5GM/100ML; 31MG/100ML; 141MG/100ML; 20MG/100ML; 12MG/100ML; 260MG/100ML | injectable | Marketed | Baxter Hlthcare |
| Potassium PhosphatesCombination | United States | 1.18GM/5ML (236MG/ML); 1.12GM/5ML, 11.8GM/50ML (236MG/ML); 11.2GM/50ML, 3.54GM/15ML (236MG/ML); 3.36GM/15ML … | solution | Marketed | Hospira |
| Potassium Phosphates in 0.9% Sodium ChlorideCombination | United States | 1.18GM/100ML (11.8MG/ML); 1.12GM/100ML, 1.18GM/250ML (4.72MG/ML); 1.12GM/250ML | solution | Marketed | Amneal |
| Sodium PhosphatesCombination | United States | 1.34GM/5ML; 1.38GM/5ML (268MG/ML, 13.4GM/50ML; 13.8GM/50ML (268MG/ML, 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Fresenius Kabi USA |
| Tis-U-SolCombination | United States | 20MG/100ML; 40MG/100ML; 6.25MG/100ML; 800MG/100ML; 8.75MG/100ML | solution | Marketed | Baxter Hlthcare |
| Tis-U-Sol in Plastic ContainerCombination | United States | 20MG/100ML; 40MG/100ML; 6.25MG/100ML; 800MG/100ML; 8.75MG/100ML | solution | Marketed | Baxter Hlthcare |
| Isolyte S PH 7.4 (Multi-Electrolyte Injection)Combination | Canada | 30 MG / 100 ML + 37 MG / 100 ML + 820 MCG / 100 ML + 370 MG / 100 ML + 530 MG / 100 ML + 500 MG / 100 ML + 12 MG / 100 ML | Solution | Marketed | B. Braun Medical INC |
| Anticoagulant Solution Citrate Phosphate Dextrose (CPD)Combination | Canada | 3.27 G / L + 25.5 G / L + 26.3 G / L + 2.51 G / L | Solution | Marketed | Maco Pharma |
| Glycerolyte 57 SolutionCombination | Canada | 57 G / 100 ML + 30 MG / 100 ML + 1.6 G / 100 ML + 124.2 MG / 100 ML + 51.7 MG / 100 ML | Solution | Marketed | Fresenius Kabi AG |
| Potassium PhosphatesCombination | Canada | 236 MG / ML + 224 MG / ML | Liquid | Marketed | Sandoz Canada Incorporated |
| Potassium Phosphates Injection, USPCombination | Canada | 236 MG / ML + 224 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| Sodium Phosphates Injection USPCombination | Canada | 268 MG / ML + 276 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| SSP+Combination | Canada | 3.05 G / L + 0.3 G / L + 0.37 G / L + 4.42 G / L + 4.05 G / L + 3.18 G / L + 1.05 G / L | Solution | Marketed | Maco Pharma |
| SSP+Combination | Canada | 3.05 G / L + 0.3 G / L + 0.37 G / L + 4.42 G / L + 4.05 G / L + 3.18 G / L + 1.05 G / L | Solution | Marketed | Maco Pharma |
| Tis-U-Sol SolutionCombination | Canada | 20 MG / 100 ML + 40 MG / 100 ML + 6.25 MG / 100 ML + 800 MG / 100 ML + 8.75 MG / 100 ML | Liquid | Marketed | Baxter Corporation |
| Isofarma Solução de Fosfato de Potássio 2 Meq/MLCombination | Brazil | Authorised | Halex Istar Indústria Farmacêutica SA | ||
| VisicolCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| DBL Potassium Dihydrogen Phosphate Concentrated Injection | Singapore | 1.361 g | injection | Authorised | Pfizer Private Limited |
| Enema JPCombination | Brazil | Authorised | JP Industria Farmaceutica S/A | ||
| Fleet EnemaCombination | Singapore | 7 g/118 ml + 19 g/118 ml | enema | Authorised | Euro Asia Medico Pte. LTD. |